1236 related articles for article (PubMed ID: 15170635)
21. Detection of antibodies to hepatitis C virus: false-negative results in an automated chemiluminescent microparticle immunoassay (ARCHITECT Anti-HCV) compared to a microparticle enzyme immunoassay (AxSYM HCV Version 3.0).
Myrmel H; Navaratnam V; Asjø B
J Clin Virol; 2005 Nov; 34(3):211-5; discussion 216-8. PubMed ID: 16112611
[TBL] [Abstract][Full Text] [Related]
22. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.
León P; López JA; Elola C; Domingo CJ; Echevarria JM
Vox Sang; 1996; 70(4):213-6. PubMed ID: 9123926
[TBL] [Abstract][Full Text] [Related]
23. Virological characteristics of hepatitis C virus infection in chronic hemodialysis patients: a cross-sectional study.
Fabrizi F; Lunghi G; Guarnori I; Raffaele L; Di Filippo S; Erba G; Pagano A; Locatelli F
Clin Nephrol; 1995 Jul; 44(1):49-55. PubMed ID: 7554533
[TBL] [Abstract][Full Text] [Related]
24. Performance of a conventional enzyme immunoassay for hepatitis C virus core antigen in the early phases of hepatitis C infection.
Aoyagi K; Iida K; Ohue C; Matsunaga Y; Tanaka E; Kiyosawa K; Yagi S
Clin Lab; 2001; 47(3-4):119-27. PubMed ID: 11294574
[TBL] [Abstract][Full Text] [Related]
25. Analysis of human immune response to potential hepatitis C viral epitopes.
Khanna A; Poduri CD; Murugan P; Kumar S; Sugunan VS; Shenoy KT; Das MR
Acta Virol; 1998 Jun; 42(3):141-5. PubMed ID: 9842443
[TBL] [Abstract][Full Text] [Related]
26. Performance characteristics of a combined hepatitis C virus core antigen and anti-hepatitis C virus antibody test in different patient groups.
Yang JF; Lin YY; Hsieh MH; Tsai CH; Liu SF; Yu ML; Dai CY; Huang JF; Lin WY; Lin ZY; Chen SC; Chuang WL
Kaohsiung J Med Sci; 2011 Jul; 27(7):258-63. PubMed ID: 21757142
[TBL] [Abstract][Full Text] [Related]
27. [Evaluation of the patients with low levels of anti-HCV positivity].
Zer Y; Karaoğlan I; Ciçek H; Karağoz ID; Sağlam M
Mikrobiyol Bul; 2009 Jan; 43(1):133-9. PubMed ID: 19334390
[TBL] [Abstract][Full Text] [Related]
28. Prolonged hepatitis C virus seroconversion in a blood donor, detected by HCV antigen test in parallel with HCV RNA.
Alvarez M; Planelles D; Vila E; Montoro J; Franco E
Vox Sang; 2004 May; 86(4):266-7. PubMed ID: 15144533
[No Abstract] [Full Text] [Related]
29. Prediction of viremia for cases of hepatitis C virus (HCV) infection using a third-generation anti-HCV enzyme immunoassay test.
Huang WS; Lu SN; Wang JH; Lee CM; Tung HD; Chen TM; ChangChien CS
Hepatogastroenterology; 2005; 52(63):893-6. PubMed ID: 15966227
[TBL] [Abstract][Full Text] [Related]
30. [Clinical value of the detection of hepatitis C virus core antigen].
Lu YC; Jiang ZY; Kuang YL; Chen WS; Tan YZ; Li DR
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jul; 23(7):635-7. PubMed ID: 17618587
[TBL] [Abstract][Full Text] [Related]
31. Accuracy of hepatitis C virus core antigen testing in pools among seroconverters.
Beer N; Shinar E; Novack L; Safi J; Soliman H; Yaari A; Goldman-Levi R; Yahalom V; Bolotin A; Sarov B
Transfusion; 2006 Oct; 46(10):1822-8. PubMed ID: 17002640
[TBL] [Abstract][Full Text] [Related]
32. [Detection of hepatitis C virus antigen in hemodialysis patients].
Wu RH
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Jun; 23(3):232-4. PubMed ID: 20104788
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous detection of anti-HCV antibody and HCV core antigen.
Ansaldi F; Icardi G
Methods Mol Biol; 2009; 510():15-23. PubMed ID: 19009250
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis C virus window-phase infections: closing the window on hepatitis C virus.
Tuke PW; Grant PR; Waite J; Kitchen AD; Eglin RP; Tedder RS
Transfusion; 2008 Apr; 48(4):594-600. PubMed ID: 18194388
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C virus core antigen: analytical performances, correlation with viremia and potential applications of a quantitative, automated immunoassay.
Medici MC; Furlini G; Rodella A; Fuertes A; Monachetti A; Calderaro A; Galli S; Terlenghi L; Olivares M; Bagnarelli P; Costantini A; De Conto F; Sainz M; Galli C; Manca N; Landini MP; Dettori G; Chezzi C
J Clin Virol; 2011 Aug; 51(4):264-9. PubMed ID: 21621454
[TBL] [Abstract][Full Text] [Related]
36. Antibody responses to the hepatitis C virus E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects.
Cerino A; Bissolati M; Cividini A; Nicosia A; Esumi M; Hayashi N; Mizuno K; Slobbe R; Oudshoorn P; Silini E; Asti M; Mondelli MU
J Med Virol; 1997 Jan; 51(1):1-5. PubMed ID: 8986942
[TBL] [Abstract][Full Text] [Related]
37. Use of overlapping synthetic peptides to characterize samples from blood donors with indeterminate results to hepatitis C virus core antigen.
León P; López JA; Elola C; Lee SR; Calmann M; Echevarría JM
Vox Sang; 1998; 75(1):32-6. PubMed ID: 9745151
[TBL] [Abstract][Full Text] [Related]
38. [The status and significance of mother-to-infant transmission of hepatitis C virus determined by nested polymerase chain reaction].
Hao F; Li M; Thaler MM; Chen G
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Jun; 11(2):127-9. PubMed ID: 15619816
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.
Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS
Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269
[TBL] [Abstract][Full Text] [Related]
40. A highly sensitive and specific enzyme-linked immunosorbent assay of antibodies to hepatitis C virus.
Eroglu C; Yildiz E; Ozturk M; Pinarbasi E
Acta Virol; 2000 Feb; 44(1):29-33. PubMed ID: 10989689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
